Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

Fri Mar 1, 2013 5:47pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130301:nPnNE69753


WALTHAM, Mass.,  March 1, 2013  /PRNewswire/ -- Alere Inc.  (NYSE: ALR), a
global leader in enabling individuals to take charge of their health at home
through the merger of rapid diagnostics and health management, today declared a
cash dividend of  $3.00  per share on its Series B Convertible Perpetual
Preferred Stock (NYSE: ALR.PR.B).  The dividend is payable on  April 15, 2013 
to holders of record of Series B stock at the close of business on  April 1,
2013.   

Such payment will cover the amount of all dividends accrued from  January 1,
2013  through  March 31, 2013.

By developing new capabilities in near-patient diagnosis, monitoring and health
information solutions, Alere enables individuals to take charge of improving
their health and quality of life at home.  Alere's global leading products and
services, as well as its new product development efforts, focus on cardiology,
infectious disease, toxicology and diabetes.  Alere is headquartered in 
Waltham, Massachusetts.

For more information about Alere, please visit our website
athttp://www.alere.com.

SOURCE  Alere Inc.


Doug Guarino, Director of Corporate Relations, +1-781-647-3900; or Jon Russell
Vice President of Finance

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.